Live Breaking News & Updates on Jeffrey testani

Stay informed with the latest breaking news from Jeffrey testani on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jeffrey testani and stay connected to the pulse of your community

Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Belgium , American , Ian-crosbie , Jeffrey-testani , Dennis-riedl , Yale-university , Company-or-sequanamedical , Company-premarket-approval , Serial-direct-sodium-removal , Heart-failure

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the results from two proof-of-concept studies, RED DESERT and SAHARA, of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been published in the prestigious pe

United-states , Canada , Belgium , American , Ian-crosbie , Jeffrey-testani , Yale-university , Company-or-sequanamedical , Company-premarket-approval , Serial-direct-sodium-removal , Heart-failure , Sequana-medical

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal ...

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance

Canada , United-states , Belgium , American , Jeffrey-testani , Ian-crosbie , Yale-university , Company-premarket-approval , Company-or-sequana , Serial-direct-sodium-removal , Heart-failure , Sequana-medical

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United-states , Florida , Tufts-medical-center , Massachusetts , New-york , Boston , Cleveland-clinic , Williamt-abraham , Gabriel-sayer , Daniel-burkhoff , Davidm-kaye , Joann-lindenfeld

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United-states , New-york , Boston , Massachusetts , Florida , Tufts-medical-center , Cleveland-clinic , Liviu-klein , Firas-zahr , Wh-wilson-tang , Kanikap-mody , Stavrosg-drakos

Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024

Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , Canada , Boston , Massachusetts , United-states , Belgium , American , Jeffrey-testani , Company-premarket-approval , Company-or-sequanamedical , Key-opinion-leader , Euronext-brussels

Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024

Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6th 2024Ghent, Belgium – 28 February 2024– Sequana Medical NV (Euronext Brussel...

Belgium , Canada , Boston , Massachusetts , United-states , American , Jeffrey-testani , Company-or-sequanamedical , Company-premarket-approval , Key-opinion-leader , Sequana-medical , Euronext-brussels

Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking ...

Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6th2024

United-states , Boston , Massachusetts , Canada , Belgium , American , Jeffrey-testani , Company-premarket-approval , Company-or-sequana , Key-opinion-leader , Sequana-medical , Euronext-brussels

Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome

Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Belgium , Canada , American , Jeffrey-testani , Company-or-sequanamedical , York-heart-association , Professor-at-yale-university , Sequana-medical , Euronext-brussels , Associate-professor , Yale-university

Sequana Medical NV: Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome

Sequana Medical NV: Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Belgium , Canada , American , Indiens-wirtschaft , Jeffrey-testani , Ihre-chancen , Professor-at-yale-university , York-heart-association , Company-or-sequanamedical , Sequana-medical , Euronext-brussels